Heidi M. Ferguson

United States Military Academy — United States

Immunology and Microbiology · Life Sciences

14h-index713citations38works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

interferon and immune responses(9), Cancer Immunotherapy and Biomarkers(6), Nanoparticle-Based Drug Delivery(5), Tryptophan and brain disorders(5), Virus-based gene therapy research(4)

Publications38 total

Electrostatically Mediated Attractive Self-Interactions and Reversible Self-Association of Fc-Fusion Proteins
Molecular Pharmaceutics·2024· 4 cited
Automated High-Throughput Matrix Assisted Laser Desorption Ionization Mass Spectrometry Methodology for Formulation Assessment of Polyethylene-Glycol-Conjugated Cytokine Proteins
Journal of Pharmaceutical Sciences·2023· 1 cited
Supplementary Data from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Data from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Figure S1 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Figure S2 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Figure S1 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Table S1 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Supplementary Data from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Table S1 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Figure S2 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Figure S3 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Data from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Figure S3 from STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2023Open Access
Abstract 11659: Comparing Rates of Acute Myocardial Infarction Between Cancer Therapies in Patients With Non-Small Cell Lung Cancer
Circulation·2022
Sonoporation‐Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression
Advanced Therapeutics·2021· 4 citedOpen Access
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold
Bioorganic & Medicinal Chemistry Letters·2021· 10 citedOpen Access
Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies
Pharmaceutics·2021· 14 citedOpen Access
Flexibility in Drug Product Development: A Perspective
Molecular Pharmaceutics·2021· 8 cited
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitors
Bioorganic & Medicinal Chemistry Letters·2021· 8 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

David Jonathan Bennett(17), Ian Knemeyer(16), Sheila Ranganath(15), Brian J. Long(14), Eric S. Muise(13), Vincenzo Pucci(13), Jason Laskey(13), Jennifer Piesvaux(13), George H. Addona(13), Jeremy Presland(13), B. Wesley Trotter(13), Samanthi A. Perera(13), Johnny E. Kopinja(12), Yanhong Ma(12), Kalyan Chakravarthy(12), Long Cui(12), Manjiri Sathe(12), Sarah Javaid(12), Ellen C. Minnihan(12), Bo‐Sheng Pan(12)